Skip to main content
Clinical Trials/TCTR20201002008
TCTR20201002008
Recruiting
Phase 2

Injection pain and anesthetic efficacy between buccal infiltration and either palatal infiltration or intraseptal injection in young permanent maxillary molar with deep caries in children: a non-inferiority randomized controlled trial

Faculty of Dentistry, Chiang Mai University0 sites88 target enrollmentOctober 2, 2020

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Deep carious lesion with pulpitis
Sponsor
Faculty of Dentistry, Chiang Mai University
Enrollment
88
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 2, 2020
End Date
October 1, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of Dentistry, Chiang Mai University

Eligibility Criteria

Inclusion Criteria

  • Patient inclusion criteria
  • 1\.Patients aged between 6â€18 years old with the American Society of Anesthesiologists I or II (ASA I or II)
  • 2\.Patients with no history of allergy to articaine or other anesthetic compounds such as epinephrine
  • 3\.Patients do not take any drugs that affect pain perception on the day of treatment 4 hours prior, such as analgesic drugs, non\-steroidal anti\-inflammatory drugs (NSAIDs).
  • 4\.Cooperative pediatric patients (Frankl behavior rating scale 3 and 4\) and can communicate
  • 5\.Patients and parents agree to participate in the study.
  • Tooth inclusion criteria
  • Pre\-operative clinical inclusion criteria
  • 1\. Permanent maxillary first molar with deep carious lesion
  • 2\. Tooth responds positively to the sensibility test by cold test and diagnosed with normal pulp, initial pulpitis, mild pulpitis, moderate pulpitis or severe pulpitis.

Exclusion Criteria

  • Patient exclusion criteria
  • 1\. Patients with underlying diseases that are contraindicated for vital pulp therapy
  • 2\. Patients with history of allergy to articaine or other anesthetic compounds such as epinephrine
  • 3\. Patients take any drugs that affect pain perception on the day of treatment 4 hours prior
  • 4\. Patients who cannot distinguish the sensation of pulpal tissue proved by sham test
  • 5\. Uncooperative pediatric patients (Frankl behavior rating scale 1 and 2\)
  • 6\. Patients and parents deny participation in the study.
  • Tooth exclusion criteria
  • Pre\-operative clinical inclusion criteria
  • 1\. Tooth with clinically diagnosis of pulp necrosis

Outcomes

Primary Outcomes

Not specified

Similar Trials